Efficacy and Safety of Oral Semaglutide versus Liraglutide and versus Placebo in Subjects with Type 2 Diabetes Mellitus

Update Il y a 4 ans
Reference: U1111-1176-6029

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the effect of once-daily dosing of 14 mg oral semaglutide versus 1.8 mg liraglutide subcutaneous and versus placebo, all in combination with metformin with or without a SGLT-2 inhibitor, on glycaemic control in subjects with type 2 diabetes mellitus (T2DM).


Inclusion criteria

  • Diabetes Mellitus, Type 2